Logo image of WGS

GENEDX HOLDINGS CORP (WGS) Stock Fundamental Analysis

NASDAQ:WGS - Nasdaq - US81663L2007 - Common Stock - Currency: USD

95.83  -5.75 (-5.66%)

After market: 93 -2.83 (-2.95%)

Fundamental Rating

3

Overall WGS gets a fundamental rating of 3 out of 10. We evaluated WGS against 108 industry peers in the Health Care Providers & Services industry. WGS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, WGS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year WGS was profitable.
In the past year WGS has reported a negative cash flow from operations.
In the past 5 years WGS always reported negative net income.
WGS had a negative operating cash flow in each of the past 5 years.
WGS Yearly Net Income VS EBIT VS OCF VS FCFWGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -200M -400M -600M

1.2 Ratios

WGS's Return On Assets of -20.42% is on the low side compared to the rest of the industry. WGS is outperformed by 78.50% of its industry peers.
Looking at the Return On Equity, with a value of -40.83%, WGS is doing worse than 69.16% of the companies in the same industry.
Industry RankSector Rank
ROA -20.42%
ROE -40.83%
ROIC N/A
ROA(3y)-66.03%
ROA(5y)-62.01%
ROE(3y)-118.9%
ROE(5y)-1173.25%
ROIC(3y)N/A
ROIC(5y)N/A
WGS Yearly ROA, ROE, ROICWGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 -1K -2K -3K -4K -5K

1.3 Margins

The Gross Margin of WGS (59.48%) is better than 79.44% of its industry peers.
In the last couple of years the Gross Margin of WGS has grown nicely.
The Profit Margin and Operating Margin are not available for WGS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y7.53%
WGS Yearly Profit, Operating, Gross MarginsWGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -100 -200

More info and screens

5

2. Health

2.1 Basic Checks

WGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
WGS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
WGS Yearly Shares OutstandingWGS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
WGS Yearly Total Debt VS Total AssetsWGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

WGS has an Altman-Z score of 4.05. This indicates that WGS is financially healthy and has little risk of bankruptcy at the moment.
WGS has a Altman-Z score of 4.05. This is in the better half of the industry: WGS outperforms 77.57% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that WGS is not too dependend on debt financing.
WGS has a better Debt to Equity ratio (0.25) than 66.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 4.05
ROIC/WACCN/A
WACC8.98%
WGS Yearly LT Debt VS Equity VS FCFWGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 200M -200M

2.3 Liquidity

WGS has a Current Ratio of 2.41. This indicates that WGS is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.41, WGS is doing good in the industry, outperforming 79.44% of the companies in the same industry.
WGS has a Quick Ratio of 2.27. This indicates that WGS is financially healthy and has no problem in meeting its short term obligations.
WGS has a Quick ratio of 2.27. This is in the better half of the industry: WGS outperforms 77.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2.41
Quick Ratio 2.27
WGS Yearly Current Assets VS Current LiabilitesWGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

WGS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 105.55%, which is quite impressive.
EPS 1Y (TTM)105.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%201.45%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%66.57%

3.2 Future

Based on estimates for the next years, WGS will show a very strong growth in Earnings Per Share. The EPS will grow by 105.66% on average per year.
The Revenue is expected to grow by 17.96% on average over the next years. This is quite good.
EPS Next Y125.62%
EPS Next 2Y131.86%
EPS Next 3Y105.66%
EPS Next 5YN/A
Revenue Next Year16.73%
Revenue Next 2Y17.17%
Revenue Next 3Y17.96%
Revenue Next 5YN/A

3.3 Evolution

WGS Yearly Revenue VS EstimatesWGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
WGS Yearly EPS VS EstimatesWGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -10 -20 -30 -40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 309.13 indicates a quite expensive valuation of WGS.
The rest of the industry has a similar Price/Earnings ratio as WGS.
When comparing the Price/Earnings ratio of WGS to the average of the S&P500 Index (29.63), we can say WGS is valued expensively.
The Price/Forward Earnings ratio is 137.01, which means the current valuation is very expensive for WGS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of WGS indicates a slightly more expensive valuation: WGS is more expensive than 61.68% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.68. WGS is valued rather expensively when compared to this.
Industry RankSector Rank
PE 309.13
Fwd PE 137.01
WGS Price Earnings VS Forward Price EarningsWGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WGS Per share dataWGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
WGS's earnings are expected to grow with 105.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.46
PEG (5Y)N/A
EPS Next 2Y131.86%
EPS Next 3Y105.66%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WGS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GENEDX HOLDINGS CORP

NASDAQ:WGS (2/21/2025, 8:00:02 PM)

After market: 93 -2.83 (-2.95%)

95.83

-5.75 (-5.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-18 2025-02-18/bmo
Earnings (Next)04-28 2025-04-28/amc
Inst Owners89.07%
Inst Owner Change23.81%
Ins Owners1.7%
Ins Owner Change-3.38%
Market Cap2.63B
Analysts76
Price Target89.76 (-6.33%)
Short Float %9.49%
Short Ratio2.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)92.71%
Min EPS beat(2)67%
Max EPS beat(2)118.42%
EPS beat(4)4
Avg EPS beat(4)61.43%
Min EPS beat(4)9.31%
Max EPS beat(4)118.42%
EPS beat(8)5
Avg EPS beat(8)24.04%
EPS beat(12)8
Avg EPS beat(12)18.04%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)17.42%
Min Revenue beat(2)17.12%
Max Revenue beat(2)17.71%
Revenue beat(4)4
Avg Revenue beat(4)14.93%
Min Revenue beat(4)2.56%
Max Revenue beat(4)22.31%
Revenue beat(8)7
Avg Revenue beat(8)7.45%
Revenue beat(12)10
Avg Revenue beat(12)3.65%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.87%
PT rev (3m)80.82%
EPS NQ rev (1m)51.16%
EPS NQ rev (3m)51.16%
EPS NY rev (1m)38.71%
EPS NY rev (3m)38.71%
Revenue NQ rev (1m)2.51%
Revenue NQ rev (3m)2.51%
Revenue NY rev (1m)0.7%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE 309.13
Fwd PE 137.01
P/S 9.85
P/FCF N/A
P/OCF N/A
P/B 12.87
P/tB 62.09
EV/EBITDA N/A
EPS(TTM)0.31
EY0.32%
EPS(NY)0.7
Fwd EY0.73%
FCF(TTM)-2.18
FCFYN/A
OCF(TTM)-2.01
OCFYN/A
SpS9.73
BVpS7.44
TBVpS1.54
PEG (NY)2.46
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.42%
ROE -40.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.48%
FCFM N/A
ROA(3y)-66.03%
ROA(5y)-62.01%
ROE(3y)-118.9%
ROE(5y)-1173.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y7.53%
F-Score4
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.4%
Cap/Sales 1.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.41
Quick Ratio 2.27
Altman-Z 4.05
F-Score4
WACC8.98%
ROIC/WACCN/A
Cap/Depr(3y)45.47%
Cap/Depr(5y)130.03%
Cap/Sales(3y)6.24%
Cap/Sales(5y)8.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%201.45%
EPS Next Y125.62%
EPS Next 2Y131.86%
EPS Next 3Y105.66%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%66.57%
Revenue Next Year16.73%
Revenue Next 2Y17.17%
Revenue Next 3Y17.96%
Revenue Next 5YN/A
EBIT growth 1Y87.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year107.39%
EBIT Next 3Y34.42%
EBIT Next 5YN/A
FCF growth 1Y81.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82%
OCF growth 3YN/A
OCF growth 5YN/A